L-DOPA treatment in Parkinson's disease: effect on dopamine and related substances in discrete brain regions.
D001921:Brain / Q000378:metabolism; D001923:Brain Chemistry; D004295:Dihydroxyphenylalanine / Q000378:metabolism / Q000627:therapeutic use*; D004298:Dopamine / Q000032:analysis*; D006801:Humans; D008750:Methyldopa / Q000032:analysis; D010300:Parkinson Disease / Q000188:drug therapy* / Q000378:metabolism; D010648:Phenylacetates / Q000032:analysis
D010648:Phenylacetates; D008750:Methyldopa; D004295:Dihydroxyphenylalanine; D004298:Dopamine